Indications
Uribel Tabs are indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.
Contraindications
CONTRADICTIONS Hypersensitivity to any of the ingredients is possible. Risk benefits should be carefully considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis, acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy).
Warnings and precautions
Do not exceed recommended dosage. If rapid pulse, dizziness or blurring of vision occurs, discontinue use immediately.
Official product information
This product has no Drugs@FDA application number in our table. DailyMed holds the labels the manufacturers submit.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Uribel Tabs
- Active substance
- methenamine, benzoic acid, phenyl salicylate, methylene blue, and hyoscyamine sulfate
- Drug class
- Belladonna alkaloids, tertiary amines, Other urologicals, Other antibacterials
- Application
- LABEL-URIBEL TABS
- NDC
- 0178-0745-01
- RxCUI
- 2670302